HBSAg Products
(Hepatitis B Virus Surface Antigen (HBsAg))
Categories
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Featured HBSAg Categories
HBSAg Antibodies
High quality antibodies with extensive validation data.
HBSAg ELISA Kits
Reliable ELISA kits for a wide range of species.
HBSAg Proteins
Proteins for various applications incl. WB, ELISA, IF etc.
Recommended HBSAg Antibodies
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Hepatitis B Virus (HBV), Mouse, Rat, Virus
Application
ELISA
Validations
- (3)
Cat. No.
ABIN723066
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse, Virus
Application
ELISA, WB, IF (p), IF (cc), IHC (fro), IHC (p)
Validations
- (11)
Cat. No.
ABIN731303
Quantity
100 μL
Datasheet
Datasheet
Reactivity
Human, Mouse, Virus
Application
ELISA, WB, IHC (fro), IHC (p)
Validations
- (1)
Cat. No.
ABIN731305
Quantity
100 μL
Datasheet
Datasheet
Recommended HBSAg ELISA Kits
Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
Cat. No.
ABIN6962773
Quantity
96 tests
Datasheet
Datasheet
Reactivity
Human
Analytical Method
Qualitative
Validations
Cat. No.
ABIN5520812
Quantity
96 tests
Datasheet
Datasheet
Reactivity
Goat
Analytical Method
Quantitative Competition ELISA
Validations
Cat. No.
ABIN992707
Quantity
96 tests
Datasheet
Datasheet
Recommended HBSAg Proteins
Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Hepatitis B Virus (HBV)
Source
Mammalian Cells
Validations
- (2)
Cat. No.
ABIN7538318
Quantity
50 μg
Datasheet
Datasheet
Reactivity
Hepatitis B Virus (HBV)
Source
Hepatitis B Virus (HBV)
Validations
- (1)
Cat. No.
ABIN934576
Quantity
1 mg
Datasheet
Datasheet
Reactivity
Hepatitis B Virus (HBV)
Source
Yeast
Validations
- (2)
Cat. No.
ABIN934803
Quantity
1 mg
Datasheet
Datasheet
Latest Publications for our HBSAg products
: "Evaluation of antiviral - passive - active immunization ("sandwich") therapeutic strategy for functional cure of chronic hepatitis B in mice." in: EBioMedicine, Vol. 49, pp. 247-257, (2020) (PubMed).: "Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T/G1764A) Mutants." in: Frontiers in microbiology, Vol. 11, pp. 1653, (2020) (PubMed).
: "Immunization with lentiviral vector‑modified dendritic cells encoding ubiquitinated hepatitis B core antigen promotes Th1 differentiation and antiviral immunity by enhancing p38 MAPK and JNK ..." in: Molecular medicine reports, Vol. 18, Issue 5, pp. 4691-4699, (2019) (PubMed).
: "Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway." in: Free radical biology & medicine, Vol. 131, pp. 225-236, (2019) (PubMed).
: "Vaccination with a DNA vaccine encoding CD317-targeting HBs antigen elicits enhanced immunity in mice." in: Biochemical and biophysical research communications, Vol. 504, Issue 4, pp. 865-870, (2019) (PubMed).
: "Zeaxanthin dipalmitate alleviates hepatic injury induced by superimposed chronic hepatitis B and non-alcoholic steatohepatitis in non-obese mice." in: Journal of Asian natural products research, Vol. 19, Issue 9, pp. 910-923, (2018) (PubMed).
: "Cisplatin Enhances Hepatitis B Virus Replication and PGC-1α Expression through Endoplasmic Reticulum Stress." in: Scientific reports, Vol. 8, Issue 1, pp. 3496, (2018) (PubMed).
: "The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients." in: Journal of the National Medical Association, Vol. 110, Issue 3, pp. 256-264, (2018) (PubMed).
: "Prevalence of chronic hepatitis B virus infection and infrastructure for its diagnosis in Madagascar: implication for the WHO's elimination strategy." in: BMC public health, Vol. 17, Issue 1, pp. 636, (2018) (PubMed).
: "Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection." in: Scientific reports, Vol. 7, pp. 45698, (2017) (PubMed).
You are here:
